Search

Your search keyword '"Anthrax vaccine -- Contracts"' showing total 15 results
Start Over Descriptor "Anthrax vaccine -- Contracts"
15 results on '"Anthrax vaccine -- Contracts"'

1. Preparing for Bioterror, Neglecting Virus Threat

Author

Hamby, Chris and Stolberg, Sheryl Gay

Subjects
Bioterrorism -- Forecasts and trends, Anthrax vaccine -- Contracts, Epidemics -- Control -- United States, Biotechnology industry -- Contracts, Public health administration -- Evaluation, Public contracts -- Forecasts and trends, Contract agreement, Market trend/market analysis, Government contract, General interest, News, opinion and commentary
Abstract

The shortage of lifesaving medical equipment last year was a searing example of the government's failed coronavirus response. As health workers resorted to wearing trash bags, one Maryland company profited [...]

Published
2021

2. DOD Retreats on Plan for Anthrax Vaccine

Author

MARSHALL, ELIOT

Subjects
United States. Department of Defense -- Contracts, Emergent BioSolutions Inc. -- Contracts, Biological products industry -- Contracts, Anthrax vaccine -- Contracts, Vaccines, Anthrax -- Drug therapy, Contract agreement, Science and technology
Abstract

The Pentagon's first comprehensive effort to protect troops against a potential bioweapon is under heavy political and regulatory fire Anthrax bacterium, once the deadly scourge of goat-hair workers, has become [...]

Published
2000

3. Emergent set to announce anthrax vaccine contract

Author

Censer, Marjorie

Subjects
Contract agreement, United States. Department of Health and Human Services -- Contracts, Anthrax vaccine -- Contracts, Pharmaceutical industry -- Contracts
Published
2010

4. U.S. Awards a Contract for Anthrax Vaccine

Subjects
Company financing, Contract agreement, Government contract, VaxGen Inc. -- Contracts, Biological products industry -- Contracts -- Finance, Anthrax vaccine -- Contracts, Public contracts -- Finance
Abstract

VaxGen, which shifted its focus to bioterrorism treatments after failures in H.I.V. research, has won an $877 million contract to supply the United States government with anthrax vaccine. VaxGen, based […]

Published
2004

5. 2 companies to develop new anthrax vaccine

Subjects
Contract agreement, VaxGen Inc. -- Contracts, Avecia Biologics Ltd. -- Contracts, Anthrax vaccine -- Contracts, Vaccines industry -- Contracts, Bioterrorism -- Safety and security measures
Published
2002

6. Anthrax vaccine contract

Subjects
Contract agreement, BioPort Corp. -- Contracts, United States. Department of Health and Human Services -- Contracts, Anthrax vaccine -- Contracts, Biological products industry -- Contracts
Abstract

The Department of Health and Human Services has awarded a $123 million contract for the manufacture and delivery of 5 million doses of licensed anthrax vaccine. The contract, awarded to [...]

Published
2005

7. Anthrax vaccine contract

Author

Worcester, Sharon

Subjects
Contract agreement, United States. Department of Health and Human Services -- Contracts, Anthrax vaccine -- Contracts
Abstract

The U.S. Department of Health and Human Services has awarded a $123 million contract for the manufacture and delivery of 5 million doses of licensed anthrax vaccine. The contract, awarded [...]

Published
2005

8. Avecia wins major US anthrax vaccines contract

Subjects
Avecia Biologics Ltd. -- Contracts, Anthrax vaccine -- Contracts, Specialty chemicals industry -- Contracts, Contract agreement, Business, Business, international, Chemicals, plastics and rubber industries, Engineering and manufacturing industries
Published
2003

9. BioPort Gets $123 Million Award for Anthrax Vaccine

Subjects
Contract agreement, Emergent BioSolutions Inc. -- Contracts, United States. Department of Health and Human Services -- Contracts, Biological products industry -- Contracts, Anthrax vaccine -- Contracts
Abstract

The Department of Health and Human Services has awarded BioPort Corp., Lansing, Mich., a $122.7 million contract to manufacture and deliver five million doses of the AVA anthrax vaccine under […]

Published
2005

10. USA: COLEY PHARMACEUTICALS AWARDED CONTRACT FOR DEVELOPMENT OF CPG OLIGONUCELEOTIDES

Subjects
United States. Army -- Contracts, Coley Pharmaceutical Group Inc. -- Contracts, Vaccines industry -- Contracts, Anthrax vaccine -- Contracts, Contract agreement, Business, Business, international, High technology industry
Abstract

(DoD) Coley Pharmaceuticals Inc., Wellesley, Mass., was awarded a $6,000,001 cost reimbursement contract for development of CpG oligonuceleotides as a vaccine adjuvant to enhance the safety and efficacy of a [...]

Published
2002

11. Footnote

Subjects
BioPort Corp. -- Contracts, Vaccines industry -- Contracts, Anthrax vaccine -- Contracts, Business, Business, general, Consumer news and advice
Abstract

Footnote: the October 6 New York Times reports that the military has entrusted its supply of anthrax vaccine to a single firm, BioPort Corp. of Lansing, Mich., but the firm [...]

Published
2001

12. Pentagon Says Anthrax Vaccine Costs Will Double

Subjects
Emergent BioSolutions Inc. -- Contracts, United States. Department of Defense -- Contracts, Biological products industry -- Contracts, Anthrax vaccine -- Contracts, Bacterial vaccines -- Contracts, Vaccines, Anthrax -- Prevention, Health, Contract agreement, Contracts, Prevention
Abstract

(CW HENDERSON PUBLISHER www.newsfile.com) -- The Pentagon has renegotiated its contract for supplies of anthrax vaccine which will mean paying more than double the current cost per dose, U.S. Defense [...]

Published
1999

13. Fight breaks out between vaccine firms

Author

Mundy, Alicia

Subjects
PharmAthene Inc. -- Political activity, PharmAthene Inc. -- Contracts, Anthrax vaccine -- Contracts, Bioterrorism -- Prevention, Bioterrorism -- Control, Public contracts -- Analysis, Lobbying -- Analysis, Pharmaceutical industry -- Political activity, Pharmaceutical industry -- Contracts, Vaccines -- Contracts, Government contract, Contract agreement, News, opinion and commentary
Published
2010

14. Emergent supplies 1m BioThrax doses

Subjects
United States. Department of Health and Human Services -- Contracts, Pharmaceutical industry -- Contracts, Anthrax vaccine -- Supply and demand, Anthrax vaccine -- Contracts, Contract agreement, Biotechnology industry, BioThrax (Medication) -- Supply and demand
Abstract

The strategic national stockpile has received nearly another million anthrax vaccine doses by way of an early delivery from Emergent BioSolutions Inc., of Rockville, Md., a company clearly positioning itself [...]

Published
2007

15. Contract will allow still-unapproved vaccine for anthrax to be developed, marketed to hospitals

Subjects
VaxGen Inc. -- Contracts, VaxGen Inc. -- Product development, Anthrax vaccine -- Supply and demand, Anthrax vaccine -- Government finance, Anthrax vaccine -- Contracts, Biological products industry -- Contracts, Biological products industry -- Product development, Anthrax -- Risk factors, Contract agreement, Business, Health care industry
Abstract

It no longer makes headlines, but anthrax is still a threat to public health. The federal government has awarded VaxGen, Brisbane, Calif., a contract to supply 75 million doses of [...]

Published
2004

Catalog

Books, media, physical & digital resources
See catalog results